| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitrous Oxide | 21 | 2023 | 107 | 6.280 |
Why?
|
| Myocardial Infarction | 15 | 2023 | 376 | 4.360 |
Why?
|
| Troponin T | 12 | 2020 | 37 | 3.210 |
Why?
|
| Anesthetics, Inhalation | 14 | 2020 | 95 | 3.070 |
Why?
|
| Depressive Disorder, Major | 6 | 2023 | 158 | 2.910 |
Why?
|
| Troponin I | 6 | 2019 | 27 | 2.470 |
Why?
|
| Vitamin B Complex | 5 | 2014 | 21 | 2.240 |
Why?
|
| Homocysteine | 7 | 2013 | 29 | 2.110 |
Why?
|
| Electroconvulsive Therapy | 3 | 2019 | 24 | 1.960 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2014 | 26 | 1.680 |
Why?
|
| Surgical Procedures, Operative | 8 | 2017 | 182 | 1.630 |
Why?
|
| Postoperative Complications | 17 | 2023 | 2207 | 1.550 |
Why?
|
| Elective Surgical Procedures | 8 | 2023 | 116 | 1.480 |
Why?
|
| Anesthesia, Inhalation | 5 | 2014 | 36 | 1.400 |
Why?
|
| Troponin | 2 | 2019 | 24 | 1.300 |
Why?
|
| Myocardium | 2 | 2020 | 529 | 1.210 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2022 | 87 | 1.160 |
Why?
|
| Electrocardiography | 8 | 2019 | 478 | 1.090 |
Why?
|
| Emergency Medical Services | 7 | 2016 | 209 | 1.040 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2023 | 152 | 1.030 |
Why?
|
| Humans | 79 | 2023 | 86643 | 0.990 |
Why?
|
| Perioperative Care | 5 | 2020 | 161 | 0.960 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2021 | 56 | 0.940 |
Why?
|
| Preoperative Care | 3 | 2021 | 397 | 0.930 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2023 | 1 | 0.920 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2023 | 11 | 0.910 |
Why?
|
| Vitamins | 2 | 2014 | 81 | 0.900 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2018 | 78 | 0.900 |
Why?
|
| Exercise Test | 2 | 2021 | 164 | 0.880 |
Why?
|
| Male | 50 | 2023 | 40965 | 0.870 |
Why?
|
| Female | 51 | 2023 | 44532 | 0.870 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2013 | 52 | 0.850 |
Why?
|
| Peptide Fragments | 2 | 2021 | 460 | 0.820 |
Why?
|
| Antidepressive Agents | 5 | 2022 | 106 | 0.810 |
Why?
|
| Hyperhomocysteinemia | 2 | 2011 | 11 | 0.780 |
Why?
|
| Coronary Angiography | 5 | 2022 | 232 | 0.780 |
Why?
|
| Postoperative Period | 7 | 2021 | 303 | 0.770 |
Why?
|
| Heart Injuries | 1 | 2020 | 16 | 0.750 |
Why?
|
| Middle Aged | 34 | 2023 | 25028 | 0.750 |
Why?
|
| Prospective Studies | 15 | 2022 | 4213 | 0.750 |
Why?
|
| Myocardial Ischemia | 2 | 2019 | 162 | 0.730 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 827 | 0.730 |
Why?
|
| Biomarkers | 11 | 2021 | 1718 | 0.710 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 582 | 0.690 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 102 | 0.680 |
Why?
|
| Long QT Syndrome | 3 | 2016 | 34 | 0.680 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 111 | 0.680 |
Why?
|
| Echocardiography, Stress | 1 | 2018 | 20 | 0.670 |
Why?
|
| Terminology as Topic | 1 | 2020 | 217 | 0.660 |
Why?
|
| Heart Diseases | 2 | 2019 | 290 | 0.650 |
Why?
|
| Tinnitus | 1 | 2018 | 21 | 0.650 |
Why?
|
| Perioperative Period | 3 | 2013 | 25 | 0.640 |
Why?
|
| Ketamine | 3 | 2023 | 24 | 0.630 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 350 | 0.630 |
Why?
|
| Depression | 5 | 2023 | 473 | 0.630 |
Why?
|
| Mood Disorders | 1 | 2018 | 81 | 0.630 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 45 | 0.620 |
Why?
|
| Risk Factors | 13 | 2023 | 5417 | 0.620 |
Why?
|
| Arterial Pressure | 1 | 2017 | 38 | 0.620 |
Why?
|
| Cardiopulmonary Resuscitation | 5 | 2016 | 190 | 0.620 |
Why?
|
| Aged | 25 | 2023 | 18415 | 0.610 |
Why?
|
| Air Ambulances | 3 | 2014 | 16 | 0.600 |
Why?
|
| Torsades de Pointes | 2 | 2013 | 7 | 0.580 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 67 | 0.570 |
Why?
|
| Life Support Care | 2 | 2007 | 49 | 0.540 |
Why?
|
| Burns | 2 | 2014 | 131 | 0.530 |
Why?
|
| Adolescent | 15 | 2021 | 8981 | 0.520 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2014 | 3 | 0.520 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 865 | 0.520 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 185 | 0.510 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 41 | 0.490 |
Why?
|
| Folic Acid | 2 | 2011 | 60 | 0.490 |
Why?
|
| Malignant Hyperthermia | 1 | 2013 | 2 | 0.480 |
Why?
|
| Orthopedic Procedures | 4 | 2020 | 128 | 0.480 |
Why?
|
| Adult | 21 | 2021 | 25648 | 0.480 |
Why?
|
| Cohort Studies | 12 | 2021 | 2767 | 0.480 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 23 | 0.480 |
Why?
|
| Vitamin B 12 | 2 | 2011 | 24 | 0.470 |
Why?
|
| Nerve Block | 1 | 2014 | 51 | 0.460 |
Why?
|
| Metoprolol | 1 | 2013 | 30 | 0.460 |
Why?
|
| Ferredoxin-NADP Reductase | 2 | 2011 | 15 | 0.450 |
Why?
|
| Exome | 1 | 2013 | 127 | 0.450 |
Why?
|
| Predictive Value of Tests | 9 | 2022 | 1673 | 0.450 |
Why?
|
| Caenorhabditis elegans | 2 | 2005 | 223 | 0.440 |
Why?
|
| Double-Blind Method | 7 | 2021 | 1823 | 0.440 |
Why?
|
| Austria | 7 | 2020 | 19 | 0.440 |
Why?
|
| Anesthetics, General | 1 | 2012 | 11 | 0.440 |
Why?
|
| Anesthesia, General | 2 | 2016 | 114 | 0.430 |
Why?
|
| Calcium Channels | 1 | 2013 | 182 | 0.430 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 819 | 0.410 |
Why?
|
| Food, Fortified | 1 | 2011 | 13 | 0.410 |
Why?
|
| Treatment Outcome | 13 | 2021 | 7993 | 0.390 |
Why?
|
| Heart Rate | 3 | 2012 | 492 | 0.390 |
Why?
|
| Consensus | 3 | 2021 | 335 | 0.380 |
Why?
|
| Computed Tomography Angiography | 2 | 2022 | 131 | 0.350 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 222 | 0.350 |
Why?
|
| Anesthesiology | 2 | 2019 | 157 | 0.340 |
Why?
|
| Receptors, Glutamate | 2 | 2005 | 24 | 0.330 |
Why?
|
| Xenon | 2 | 2005 | 7 | 0.330 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 6509 | 0.320 |
Why?
|
| Genetic Variation | 2 | 2011 | 1351 | 0.320 |
Why?
|
| Cross-Over Studies | 3 | 2020 | 399 | 0.310 |
Why?
|
| Glutamic Acid | 2 | 2022 | 152 | 0.310 |
Why?
|
| Endpoint Determination | 2 | 2020 | 60 | 0.310 |
Why?
|
| Pilot Projects | 2 | 2022 | 839 | 0.300 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 297 | 0.300 |
Why?
|
| Anesthesia | 1 | 2009 | 164 | 0.300 |
Why?
|
| Genome, Human | 1 | 2011 | 756 | 0.290 |
Why?
|
| Retrospective Studies | 12 | 2023 | 8489 | 0.290 |
Why?
|
| Wounds and Injuries | 3 | 2011 | 231 | 0.280 |
Why?
|
| Young Adult | 6 | 2021 | 5976 | 0.280 |
Why?
|
| Genomics | 1 | 2011 | 720 | 0.280 |
Why?
|
| Emergency Medicine | 1 | 2007 | 123 | 0.280 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2005 | 2 | 0.280 |
Why?
|
| Syntaxin 1 | 1 | 2005 | 8 | 0.280 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 14 | 0.270 |
Why?
|
| SNARE Proteins | 1 | 2005 | 26 | 0.270 |
Why?
|
| Risk Assessment | 7 | 2021 | 2261 | 0.270 |
Why?
|
| Prognosis | 6 | 2020 | 3679 | 0.270 |
Why?
|
| Child | 9 | 2020 | 6927 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 2271 | 0.250 |
Why?
|
| Mutation | 2 | 2013 | 3968 | 0.240 |
Why?
|
| Hospital Mortality | 2 | 2023 | 349 | 0.230 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2023 | 11 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 1052 | 0.230 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2004 | 109 | 0.220 |
Why?
|
| United States | 6 | 2023 | 6672 | 0.220 |
Why?
|
| Spine | 2 | 2015 | 102 | 0.220 |
Why?
|
| Preoperative Period | 2 | 2013 | 91 | 0.210 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2022 | 47 | 0.210 |
Why?
|
| Research | 1 | 2003 | 253 | 0.210 |
Why?
|
| Coronary Circulation | 1 | 2022 | 130 | 0.200 |
Why?
|
| Unnecessary Procedures | 1 | 2021 | 51 | 0.200 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 54 | 0.200 |
Why?
|
| Abdomen | 1 | 2021 | 122 | 0.200 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 148 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2003 | 168 | 0.190 |
Why?
|
| Administration, Inhalation | 2 | 2018 | 188 | 0.190 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2000 | 14 | 0.190 |
Why?
|
| Huntington Disease | 1 | 2000 | 37 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2357 | 0.190 |
Why?
|
| Heart Arrest | 2 | 2021 | 265 | 0.190 |
Why?
|
| Infarction | 1 | 2020 | 26 | 0.190 |
Why?
|
| Methyl Ethers | 1 | 2000 | 33 | 0.190 |
Why?
|
| Coronary Vessels | 1 | 2022 | 177 | 0.190 |
Why?
|
| Appendectomy | 1 | 2000 | 33 | 0.190 |
Why?
|
| Isoquinolines | 1 | 2000 | 72 | 0.190 |
Why?
|
| Up-Regulation | 3 | 2017 | 712 | 0.180 |
Why?
|
| Age Factors | 4 | 2015 | 1851 | 0.180 |
Why?
|
| Research Design | 2 | 2020 | 594 | 0.180 |
Why?
|
| Anxiety | 1 | 2022 | 287 | 0.180 |
Why?
|
| Emergencies | 1 | 2000 | 113 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 120 | 0.180 |
Why?
|
| Veterans | 1 | 2020 | 72 | 0.180 |
Why?
|
| Survival Analysis | 2 | 2016 | 1538 | 0.180 |
Why?
|
| Accelerometry | 1 | 2019 | 36 | 0.180 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1019 | 0.170 |
Why?
|
| Pericardium | 1 | 2019 | 65 | 0.170 |
Why?
|
| Hip Joint | 1 | 2019 | 55 | 0.170 |
Why?
|
| Medicare | 1 | 2023 | 410 | 0.170 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 114 | 0.170 |
Why?
|
| Walking | 1 | 2019 | 87 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 96 | 0.170 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 72 | 0.170 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 413 | 0.170 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 148 | 0.160 |
Why?
|
| Enzyme Stability | 1 | 2017 | 39 | 0.160 |
Why?
|
| Time Factors | 7 | 2019 | 5210 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3640 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 860 | 0.150 |
Why?
|
| Adipose Tissue | 1 | 2019 | 240 | 0.150 |
Why?
|
| Hypotension | 1 | 2017 | 70 | 0.150 |
Why?
|
| Patient Outcome Assessment | 2 | 2016 | 84 | 0.150 |
Why?
|
| Age Distribution | 2 | 2014 | 204 | 0.150 |
Why?
|
| Anesthetics | 2 | 2009 | 48 | 0.140 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.140 |
Why?
|
| Echocardiography | 1 | 2021 | 911 | 0.140 |
Why?
|
| Missouri | 2 | 2017 | 19 | 0.140 |
Why?
|
| Exercise | 1 | 2019 | 315 | 0.140 |
Why?
|
| Genotype | 2 | 2013 | 1851 | 0.140 |
Why?
|
| Child, Preschool | 6 | 2015 | 3612 | 0.140 |
Why?
|
| Blood Cells | 1 | 2015 | 33 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2705 | 0.130 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 45 | 0.130 |
Why?
|
| Pregnancy | 1 | 2022 | 2894 | 0.130 |
Why?
|
| Sample Size | 2 | 2013 | 130 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 39 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2014 | 173 | 0.120 |
Why?
|
| Single-Blind Method | 2 | 2017 | 153 | 0.120 |
Why?
|
| Body Surface Area | 1 | 2013 | 36 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 965 | 0.120 |
Why?
|
| Fluid Therapy | 1 | 2013 | 50 | 0.110 |
Why?
|
| Stereoisomerism | 1 | 2013 | 102 | 0.110 |
Why?
|
| Incidence | 2 | 2016 | 1577 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 487 | 0.110 |
Why?
|
| Skiing | 1 | 2012 | 3 | 0.110 |
Why?
|
| Preanesthetic Medication | 2 | 2010 | 6 | 0.110 |
Why?
|
| Contusions | 1 | 2012 | 9 | 0.110 |
Why?
|
| Algorithms | 2 | 2013 | 1830 | 0.110 |
Why?
|
| Survival Rate | 2 | 2014 | 1863 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2013 | 207 | 0.110 |
Why?
|
| Pain Measurement | 1 | 2014 | 321 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 53 | 0.110 |
Why?
|
| Human Genome Project | 1 | 2011 | 19 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 1801 | 0.100 |
Why?
|
| Edible Grain | 1 | 2011 | 9 | 0.100 |
Why?
|
| Folic Acid Antagonists | 1 | 2011 | 19 | 0.100 |
Why?
|
| Risk | 1 | 2013 | 674 | 0.100 |
Why?
|
| Infant | 4 | 2012 | 3046 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 240 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 999 | 0.100 |
Why?
|
| Shock, Hemorrhagic | 1 | 2010 | 11 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2012 | 131 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2011 | 118 | 0.100 |
Why?
|
| Rescue Work | 2 | 2012 | 7 | 0.090 |
Why?
|
| Neck Dissection | 1 | 2010 | 65 | 0.090 |
Why?
|
| Causality | 1 | 2010 | 81 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2010 | 229 | 0.090 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2010 | 60 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 243 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 307 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 421 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2012 | 161 | 0.090 |
Why?
|
| Environment | 1 | 2011 | 219 | 0.090 |
Why?
|
| Length of Stay | 2 | 2021 | 702 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2011 | 319 | 0.080 |
Why?
|
| Aminophylline | 1 | 2008 | 14 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 673 | 0.080 |
Why?
|
| Anesthesia, Intravenous | 1 | 2008 | 35 | 0.080 |
Why?
|
| Germany | 1 | 2007 | 72 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 379 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2013 | 751 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 1036 | 0.080 |
Why?
|
| Base Sequence | 1 | 2011 | 2330 | 0.080 |
Why?
|
| Shock | 1 | 2007 | 42 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 1156 | 0.080 |
Why?
|
| Rats | 2 | 2022 | 3990 | 0.080 |
Why?
|
| Genetic Linkage | 1 | 2009 | 623 | 0.080 |
Why?
|
| Smoking | 1 | 2011 | 609 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2009 | 677 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 746 | 0.070 |
Why?
|
| Trauma Centers | 1 | 2007 | 116 | 0.070 |
Why?
|
| Europe | 1 | 2007 | 309 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 943 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 1186 | 0.070 |
Why?
|
| Phenotype | 1 | 2013 | 2378 | 0.070 |
Why?
|
| Animals | 5 | 2022 | 26582 | 0.070 |
Why?
|
| Oxygen | 1 | 2010 | 726 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2004 | 45 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2004 | 176 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2004 | 66 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2008 | 709 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2232 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1014 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2023 | 44 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 67 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2023 | 93 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2023 | 120 | 0.050 |
Why?
|
| Isoflurane | 1 | 2003 | 64 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 223 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 2 | 2016 | 109 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1456 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 92 | 0.050 |
Why?
|
| Multidetector Computed Tomography | 1 | 2022 | 54 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2004 | 373 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 302 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2020 | 80 | 0.050 |
Why?
|
| Ambulances | 1 | 2000 | 15 | 0.050 |
Why?
|
| Multiple Trauma | 1 | 2000 | 34 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 2000 | 25 | 0.050 |
Why?
|
| Morbidity | 1 | 2020 | 148 | 0.050 |
Why?
|
| Anesthesia, Dental | 1 | 2019 | 4 | 0.040 |
Why?
|
| Contraindications, Drug | 1 | 2019 | 5 | 0.040 |
Why?
|
| Analgesia, Obstetrical | 1 | 2019 | 21 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 46 | 0.040 |
Why?
|
| Hippocampus | 1 | 2022 | 442 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2019 | 64 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 304 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2379 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 814 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2000 | 373 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 145 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 429 | 0.040 |
Why?
|
| Anesthesia, Spinal | 1 | 2016 | 15 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 27 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 674 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 572 | 0.030 |
Why?
|
| Pancytopenia | 1 | 2015 | 23 | 0.030 |
Why?
|
| Leukopenia | 1 | 2015 | 65 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1169 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 752 | 0.030 |
Why?
|
| Anemia | 1 | 2015 | 128 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 183 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 916 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 300 | 0.030 |
Why?
|
| Snow Sports | 1 | 2012 | 1 | 0.030 |
Why?
|
| Mountaineering | 1 | 2012 | 2 | 0.030 |
Why?
|
| Bicycling | 1 | 2012 | 12 | 0.030 |
Why?
|
| Spinal Injuries | 1 | 2012 | 22 | 0.030 |
Why?
|
| Facial Injuries | 1 | 2012 | 19 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1991 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2012 | 52 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2012 | 84 | 0.030 |
Why?
|
| Utilization Review | 1 | 2011 | 21 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2501 | 0.030 |
Why?
|
| Rural Population | 1 | 2011 | 136 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 239 | 0.020 |
Why?
|
| Urban Population | 1 | 2011 | 213 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2008 | 1143 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 297 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 555 | 0.020 |
Why?
|
| Critical Illness | 1 | 2011 | 294 | 0.020 |
Why?
|
| Anesthetics, Intravenous | 1 | 2008 | 41 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 2008 | 65 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1621 | 0.020 |
Why?
|
| Emergency Medical Technicians | 1 | 2005 | 14 | 0.020 |
Why?
|
| Manikins | 1 | 2005 | 41 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 102 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2003 | 5 | 0.010 |
Why?
|
| Midazolam | 1 | 2003 | 48 | 0.010 |
Why?
|
| Anesthesia Recovery Period | 1 | 2003 | 56 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2005 | 334 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 144 | 0.010 |
Why?
|